Angiogenic Factor Expression During Fractionated Irradiation

NCT02072720 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Primary Esophageal Carcinoma

Interventions

DRUG: Bevacizumab

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]
[object Object]